Insight Advisors, LLC Agenus Inc Transaction History

Insight Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$0.53 - $0.93 $1,060 - $1,860	2,000 Added 12.36%	18,180 $10,000
Q4 2023 Jan 23, 2024	BUY	$0.63 - $1.14 $630 - $1,140	1,000 Added 6.59%	16,180 $13,000
Q2 2023 Aug 07, 2023	BUY	$1.31 - $2.04 $2,816 - $4,386	2,150 Added 16.5%	15,180 $24,000
Q2 2022 Aug 11, 2022	BUY	$1.3 - $2.64 $110 - $224	85 Added 0.66%	13,030 $33,000
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $14,666 - $19,525	2,945 Added 29.45%	12,945 $56,000
Q4 2020 Feb 12, 2021	BUY	$3.17 - $4.49 $31,700 - $44,900	10,000 New	10,000 $32,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Insight Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Insight Advisors, LLC with notifications on news.